Skip header and navigation

Refine By

3 records – page 1 of 1.

Cancer incidence and mortality in the European Union: cancer registry data and estimates of national incidence for 1990.

https://arctichealth.org/en/permalink/ahliterature22043
Source
Eur J Cancer. 1997 Jun;33(7):1075-107
Publication Type
Article
Date
Jun-1997
Author
R J Black
F. Bray
J. Ferlay
D M Parkin
Author Affiliation
Unit of Descriptive Epidemiology, International Agency for Research on Cancer, Lyon, France.
Source
Eur J Cancer. 1997 Jun;33(7):1075-107
Date
Jun-1997
Language
English
Publication Type
Article
Keywords
Adolescent
Adult
Aged
Child
Child, Preschool
Europe - epidemiology
European Union - statistics & numerical data
Female
Humans
Incidence
Infant
Infant, Newborn
Male
Middle Aged
Neoplasms - epidemiology - mortality
Registries - statistics & numerical data
Research Support, Non-U.S. Gov't
Sex Distribution
Abstract
Members of the European Network of Cancer Registries (ENCR) provide population-based data on cancer incidence for some countries and regions of Europe. These were supplemented by estimates in order to provide comparable information on cancer incidence and mortality in the 15 member states of the European Union (EU). The estimated numbers of new cases of cancer (excluding nonmelanoma skin cancer) in 1990 were approximately 706,900 in men and 644,200 in women. Approximately 497,500 men and 398,200 women died of cancer in the same year. The main sites of incident cases in men were lung (21%), large bowel (13%), prostate (12%), bladder (7%) and stomach (7%). For women, the predominant sites were breast (28%), large bowel (15%), lung (6%), uterine corpus (5%) and stomach (5%). The overall incidence rates for males were highest in continental Western Europe (France, The Netherlands, Austria, Luxembourg, Belgium, Germany and Italy) while the rates of Greece, Portugal, Sweden, Ireland, Spain, Finland, the U.K. and Denmark were below the average value for the EC. Rates for females were highest in Northern and Western Europe, with the exception of France, which had a relatively low rate for females, in common with Greece, Spain and Portugal. The geographical variations in incidence of the major cancers are discussed in relation to risk factors. The estimates show the substantial burden of cancer in European Union populations, but there are also indications of effects of past preventive measures and there is scope for further intervention. Cancer registries are an important source of information for cancer control since they provide population-based incidence and survival statistics. These, along with mortality data, are required to obtain a full picture of the frequency of cancer and its effects at the population level. Some 44% of the EU population is covered by registries. The European Network of Cancer Registries aims to standardise the information provided by existing registries and to provide practical assistance to those in development.
Notes
Comment In: Eur J Cancer. 1997 Jun;33(7):991-69376203
Erratum In: Eur J Cancer 1997 Dec;33(14):2440
PubMed ID
9376190 View in PubMed
Less detail

Childhood leukaemia following the Chernobyl accident: the European Childhood Leukaemia-Lymphoma Incidence Study (ECLIS).

https://arctichealth.org/en/permalink/ahliterature24601
Source
Eur J Cancer. 1992;29A(1):87-95
Publication Type
Article
Date
1992
Author
D M Parkin
E. Cardis
E. Masuyer
H P Friedl
H. Hansluwka
D. Bobev
E. Ivanov
J. Sinnaeve
J. Augustin
I. Plesko
Author Affiliation
International Agency for Research on Cancer, Lyon, France.
Source
Eur J Cancer. 1992;29A(1):87-95
Date
1992
Language
English
Publication Type
Article
Keywords
Accidents
Adolescent
Child
Child, Preschool
Europe - epidemiology
Female
Humans
Incidence
Infant
Infant, Newborn
Leukemia, Radiation-Induced - epidemiology
Lymphoma - epidemiology
Male
Neoplasms, Radiation-Induced - epidemiology
Nuclear Reactors
Radiation Dosage
Radioactive Fallout - adverse effects
Research Support, Non-U.S. Gov't
Ukraine - epidemiology
Abstract
The objective of the European Childhood Leukaemia-Lymphoma Incidence Study (ECLIS) is to investigate trends in incidence rates of childhood leukaemia and lymphoma in Europe, in relation to the exposure to radiation which resulted from the accident at the Chernobyl nuclear power plant in April 1986. In this first report, the incidence of leukaemia in children aged 0-14 is presented from cancer registries in 20 European countries for the period 1980-1988. Risk of leukaemia in 1987-1988 (8-32 months post-accident) relative to that before 1986, is compared with estimated average dose of radiation received by the population in 30 geographic areas. The observed changes in incidence do not relate to exposure. The period of follow-up is so far rather brief, and the study is planned to continue for at least 10 years.
PubMed ID
1445751 View in PubMed
Less detail

Estimates of cancer incidence and mortality in Europe in 1995.

https://arctichealth.org/en/permalink/ahliterature19392
Source
Eur J Cancer. 2002 Jan;38(1):99-166
Publication Type
Article
Date
Jan-2002
Author
F. Bray
R. Sankila
J. Ferlay
D M Parkin
Author Affiliation
Unit of Descriptive Epidemiology, International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France. bray@iarc.fr
Source
Eur J Cancer. 2002 Jan;38(1):99-166
Date
Jan-2002
Language
English
Publication Type
Article
Keywords
Adolescent
Adult
Age Distribution
Aged
Child
Child, Preschool
Europe - epidemiology
Female
Humans
Incidence
Infant
Infant, Newborn
Male
Middle Aged
Neoplasms - mortality
Registries
Research Support, Non-U.S. Gov't
Sex Distribution
Abstract
Cancer incidence and mortality estimates for 1995 are presented for the 38 countries in the four United Nations-defined areas of Europe, using World Health Organization mortality data and published estimates of incidence from national cancer registries. Additional estimation was required where national incidence data was not available, and the method involved incorporating the high quality incidence and mortality data available from the expanding number of population-based cancer registries in Europe. There were an estimated 2.6 million new cases of cancer in Europe in 1995, representing over one-quarter of the world burden of cancer. The corresponding number of deaths from cancer was approximately 1.6 million. After adjusting for differing population age structures, overall incidence rates in men were highest in the Western European countries (420.9 per 100,000), with only Austria having a rate under 400. Eastern European men had the second highest rates of cancer (414.2), with extremely high rates being observed in Hungary (566.6) and in the Czech Republic (480.5). The lowest male all-cancer rate by area was observed in the Northern European countries, with fairly low rates seen in Sweden (356.6) and the UK (377.8). In contrast to men, the highest rates in women were observed in Northern Europe (315.9) and were particularly high in Denmark (396.2) and the other Nordic countries excepting Finland. The rates of cancer in Eastern European women were lower than in the other three areas, although as with men, female rates were very high in Hungary (357.2) and in the Czech Republic (333.6). There was greater disparity in the mortality rates within Europe--generally, rates were highest in Eastern European countries, notably in Hungary, reflecting a combination of poorer cancer survival rates and a higher incidence of the more lethal neoplasms, notably cancer of the lung. Lung cancer, with an estimated 377,000 cases, was the most common cancer in Europe in 1995. Rates were particularly high in much of Eastern Europe reflecting current and past tobacco smoking habits of many of its inhabitants. Together with cancers of colon and rectum (334,000), and female breast (321,000), the three cancers represented approximately 40% of new cases in Europe. In men, the most common primary sites were lung (22% of all cancer cases), colon and rectum (12%) and prostate (11%), and in females, breast (26%), colon and rectum (14%) and stomach (7%). The number of deaths is determined by survival, as well as incidence; by far the most common cause of death was lung cancer (330,000)--about one-fifth of the total number of cancer deaths in Europe in 1995. Deaths from cancers of the colon and rectum (189,000) ranked second, followed by deaths from stomach cancer (152,000), which due to poorer survival ranked higher than breast cancer (124,000). Lung cancer was the most common cause of death from cancer in men (29%). Breast cancer was the leading cause of death in females (17%). Cancer registries are a unique source of information on cancer incidence and survival, and are used here with national mortality to demonstrate the very substantial burden of cancer in Europe, and the scope for prevention. Despite some provisos about data quality, the general patterns which emerge in Europe verify the role of past exposures and interventions, and more importantly, firmly establish the need for cancer control measures which target specific populations. In particular, there is a clear urgency to combat the ongoing tobacco epidemic, now prevalent in much of Europe, particularly in the Eastern countries.
PubMed ID
11750846 View in PubMed
Less detail